Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Cecil Czerkinsky"'
Autor:
Filippo Massa, PhD, Marion Cremoni, MD, Alexandre Gérard, MD, Hanen Grabsi, Lory Rogier, Mathilde Blois, MD, Chloé Couzin, MD, Nadia Ben Hassen, Matthieu Rouleau, PhD, Susana Barbosa, PhD, Emanuela Martinuzzi, PhD, Julien Fayada, Ghislaine Bernard, MD-PhD, Guillaume Favre, MD-PhD, Paul Hofman, MD-PhD, Vincent L.M. Esnault, MD-PhD, Cecil Czerkinsky, MD-PhD, Barbara Seitz-Polski, MD-PhD, Nicolas Glaichenhaus, PhD, Antoine Sicard, MD-PhD
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103679- (2021)
Background: The immunogenicity of a two-dose mRNA COVID-19 vaccine regimen is low in kidney transplant (KT) recipients. Here, we provide a thorough assessment of the immunogenicity of a three-dose COVID-19 vaccine regimen in this population. Methods:
Externí odkaz:
https://doaj.org/article/6aec33f0dd6e4ddba8069d07e0e047f1
Autor:
Min Jung Kim, Young-hye Moon, Heejoo Kim, Semi Rho, Young Kee Shin, Manki Song, Richard Walker, Cecil Czerkinsky, Dong Wook Kim, Jae-Ouk Kim
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Shigella is a highly prevalent bacterium causing acute diarrhea and dysentery in developing countries. Shigella infections are treated with antibiotics but Shigellae are increasingly resistant to these drugs. Vaccination can be a countermeasure again
Externí odkaz:
https://doaj.org/article/67aea946af844ba083edfb35b05fd9a4
Autor:
Byoung-Shik Shim, In Su Cheon, Eugene Lee, Sung-Moo Park, Youngjoo Choi, Dae-Im Jung, Eunji Yang, Jung-ah Choi, June Young Chun, Jae-Ouk Kim, Cheol-Heui Yun, Cecil Czerkinsky, Man Ki Song
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Potential use of cholera toxin (CT) as a mucosal vaccine adjuvant has been documented in a variety of animal models. However, native CT is highly toxic to be used as a mucosal adjuvant in humans. Here, we demonstrate a new approach to generate a muco
Externí odkaz:
https://doaj.org/article/7d69a1718ec949bcb03472ee0af2459b
Autor:
Anuradha Sinha, Suman Kanungo, Deok Ryun Kim, Byomkesh Manna, Manki Song, Ju Yeon Park, Bisakha Haldar, Prashant Sharma, Aiyel Haque Mallick, Soon Ae Kim, Sudhir Babji, Dipika Sur, Gagandeep Kang, Mohammad Ali, William A Petri Jr., Thomas F Wierzba, Cecil Czerkinsky, Ranjan Kumar Nandy, Ayan Dey
Publikováno v:
Heliyon, Vol 4, Iss 1 (2018)
Background: Assessing immune response after rotavirus vaccination consists in measuring serum or plasma IgA and IgG antibodies, but these assays provide very little information about the mucosal immune response. Thus the development of assays for det
Externí odkaz:
https://doaj.org/article/d0fc51d64a544527989553c263b16277
Autor:
Suman Kanungo, Deok Ryun Kim, Bisakha Haldar, Cynthia Snider, Uma Nalavade, Soon Ae Kim, Ju Yeon Park, Anuradha Sinha, Aiyel Haque Mallick, Byomkesh Manna, Dipika Sur, Ranjan Kumar Nandy, Jagadish M. Deshpande, Cecil Czerkinsky, Thomas F Wierzba, William A Petri Jr., Mohammad Ali, Ayan Dey
Publikováno v:
Heliyon, Vol 3, Iss 1 (2017)
Background: The final endgame strategy of global polio eradication initiative includes switching from trivalent oral poliovirus vaccines (tOPV) to bivalent oral polio vaccine (bOPV), and introduction of inactivated poliovirus vaccine (IPV). This stud
Externí odkaz:
https://doaj.org/article/24e94aad490d4020a11b46e44676e115
Autor:
Ayan Dey, Natalie A Molodecky, Harish Verma, Prashant Sharma, Jae Seung Yang, Giulietta Saletti, Mohammad Ahmad, Sunil K Bahl, Thomas F Wierzba, Ranjan K Nandy, Jagadish M Deshpande, Roland W Sutter, Cecil Czerkinsky
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146010 (2016)
BACKGROUND:The "gold standard" for assessing mucosal immunity after vaccination with poliovirus vaccines consists in measuring virus excretion in stool after challenge with oral poliovirus vaccine (OPV). This testing is time and resource intensive, a
Externí odkaz:
https://doaj.org/article/934e3cafdcef4d64a319335b2ea8c32b
Autor:
Hae-Jung Park, Boris Ferko, Young-Ho Byun, Joo-Hye Song, Gye-Yeong Han, Elisabeth Roethl, Andrej Egorov, Thomas Muster, Baiklin Seong, Mi-Na Kweon, Manki Song, Cecil Czerkinsky, Huan H Nguyen
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39921 (2012)
The nonstructural protein 1 (NS1) of influenza A virus (IAV) enables the virus to disarm the host cell type 1 IFN defense system. Mutation or deletion of the NS1 gene leads to attenuation of the virus and enhances host antiviral response making such
Externí odkaz:
https://doaj.org/article/b0511f0df3d7418ca52e1076f2754670
Autor:
Byoung-Shik Shim, Young Ki Choi, Cheol-Heui Yun, Eu-Gene Lee, Yoon Seong Jeon, Sung-Moo Park, In Su Cheon, Dong-Hyun Joo, Chung Hwan Cho, Min-Suk Song, Sang-Uk Seo, Young-Ho Byun, Hae-Jung Park, Haryoung Poo, Baik Lin Seong, Jae Ouk Kim, Huan Huu Nguyen, Konrad Stadler, Dong Wook Kim, Kee-Jong Hong, Cecil Czerkinsky, Man Ki Song
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27953 (2011)
BackgroundThe ectodomain of matrix protein 2 (M2e) of influenza A virus is a rationale target antigen candidate for the development of a universal vaccine against influenza as M2e undergoes little sequence variation amongst human influenza A strains.
Externí odkaz:
https://doaj.org/article/672b846a88ac4c83937f716af3e0d5df
Autor:
Huan H Nguyen, Terrence M Tumpey, Hae-Jung Park, Young-Ho Byun, Linh D Tran, Van D Nguyen, Paul E Kilgore, Cecil Czerkinsky, Jacqueline M Katz, Baik Lin Seong, Jae Min Song, Young Bong Kim, Hoa T Do, Tung Nguyen, Cam V Nguyen
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10152 (2010)
BACKGROUND: Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Att
Externí odkaz:
https://doaj.org/article/a70752a7f957440aba4c48e37aea5ad1
Autor:
Emanuela Martinuzzi, Jonathan Benzaquen, Olivier Guerin, Sylvie Leroy, Thomas Simon, Marius Ilie, Véronique Hofman, Maryline Allegra, Virginie Tanga, Emeline Michel, Jacques Boutros, Charlotte Maniel, Antoine Sicard, Nicolas Glaichenhaus, Cecil Czerkinsky, Philippe Blancou, Paul Hofman, Charles H Marquette
Publikováno v:
Clinical Infectious Diseases. 75:2053-2059
Background Mucosal antibodies can prevent virus entry and replication in mucosal epithelial cells and therefore virus shedding. Parenteral booster injection of a vaccine against a mucosal pathogen promotes stronger mucosal immune responses following
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c88fcff2de799df0fa72afd21a67a27f
https://doi.org/10.1093/cid/ciac378
https://doi.org/10.1093/cid/ciac378